Definitive Radiotherapy for T1–2 Hypopharyngeal Cancer: A Single-Institution Experience


      To analyze the outcome in T1–2 hypopharyngeal cancer (HPC) patients treated with definitive radiotherapy (RT).

      Patients and Methods

      A total of 103 patients with T1–2 hypopharyngeal squamous cell carcinoma treated with radical RT between March 2000 and June 2008 at our institution were analyzed. Pre-RT neck dissection (ND) was performed in 26 patients with advanced neck disease. Chemotherapy was used concurrently with RT in 14 patients. Sixty patients were associated with synchronous or metachronous malignancies. The median follow-up for surviving patients was 41 months.


      The 3-year overall and cause-specific survival rates were 70% and 79%, respectively. The 3-year local control rates were 87% for T1 and 83% for T2 disease. The ultimate local control rate was 89%, including 7 patients in whom salvage was successful. The ultimate local control rate with laryngeal preservation was 82%. Tumors of the medial wall of the pyriform sinus tended to have lower control rates compared with tumors of the lateral or posterior pharyngeal wall. Among patients with N2b–3 disease, the 3-year regional control rates were 74% for patients with pre-RT ND and 40% for patients without ND. The 3-year locoregional control rates were as follows: Stage I, 100%; Stage II, 84%; Stage III, 67%; Stage IVA, 43%; Stage IVB, 67%. Forty-two patients developed disease recurrence, with 29 (70%) patients developing recurrence within the first year. Of the 103 patients, 6 developed late complications higher than or equal to Grade 3.


      Definitive RT accomplished a satisfactory local control rate and contributed to organ preservation.
      To read this article in full you will need to make a payment
      ASTRO Member Login
      ASTRO Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Ioka A.
        • Tsukuma H.
        • Ajiki W.
        • et al.
        Trends in head and neck cancer incidence in Japan during 1965-1999.
        Jpn J Clin Oncol. 2005; 35: 45-47
      1. NationalCancerInstitute. Age-adjusted SEER incidence and U.S. death rates and 5-year survival rates by primary cancer sites, sex and time period. (accessed April 25, 2010).

        • Pignon J.P.
        • le Maitre A.
        • Maillard E.
        • et al.
        Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients.
        Radiother Oncol. 2009; 92: 4-14
        • Hall S.F.
        • Groome P.A.
        • Irish J.
        • et al.
        Radiotherapy or surgery for head and neck squamous cell cancer: Establishing the baseline for hypopharyngeal carcinoma?.
        Cancer. 2009; 115: 5711-5722
        • Lefebvre J.L.
        • Chevalier D.
        • Luboinski B.
        • et al.
        Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group.
        J Natl Cancer Inst. 1996; 88: 890-899
        • Amdur R.J.
        • Mendenhall W.M.
        • Stringer S.P.
        • et al.
        Organ preservation with radiotherapy for T1-T2 carcinoma of the pyriform sinus.
        Head Neck. 2001; 23: 353-362
        • Pameijer F.A.
        • Mancuso A.A.
        • Mendenhall W.M.
        • et al.
        Evaluation of pretreatment computed tomography as a predictor of local control in T1/T2 pyriform sinus carcinoma treated with definitive radiotherapy.
        Head Neck. 1998; 20: 159-168
        • Garden A.S.
        • Morrison W.H.
        • Clayman G.L.
        • et al.
        Early squamous cell carcinoma of the hypopharynx: Outcomes of treatment with radiation alone to the primary disease.
        Head Neck. 1996; 18: 317-322
        • Rabbani A.
        • Amdur R.J.
        • Mancuso A.A.
        • et al.
        Definitive radiotherapy for T1-T2 squamous cell carcinoma of pyriform sinus.
        Int J Radiat Oncol Biol Phys. 2008; 72: 351-355
        • Raghavan U.
        • Quraishi S.
        • Bradley P.J.
        Multiple primary tumors in patients diagnosed with hypopharyngeal cancer.
        Otolaryngol Head Neck Surg. 2003; 128: 419-425
        • Spector J.G.
        • Sessions D.G.
        • Haughey B.H.
        • et al.
        Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
        Laryngoscope. 2001; 111: 1079-1087
        • Nakamura K.
        • Shioyama Y.
        • Kawashima M.
        • et al.
        Multi-institutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapy.
        Int J Radiat Oncol Biol Phys. 2006; 65: 1045-1050
        • Yoshimura R.
        • Kagami Y.
        • Ito Y.
        • et al.
        Outcomes in patients with early-stage hypopharyngeal cancer treated with radiotherapy.
        Int J Radiat Oncol Biol Phys. 2010; 77: 1017-1023
        • Morimoto M.
        • Nishiyama K.
        • Nakamura S.
        • et al.
        Significance of endoscopic screening and endoscopic resection for esophageal cancer in patients with hypopharyngeal cancer.
        Jpn J Clin Oncol. 2010; 40: 938-943
        • Inoue T.
        • Shigematsu Y.
        • Sato T.
        Treatment of carcinoma of the hypopharynx.
        Cancer. 1973; 31: 649-655
        • Meoz-Mendez R.T.
        • Fletcher G.H.
        • Guillamondegui O.M.
        • et al.
        Analysis of the results of irradiation in the treatment of squamous cell carcinomas of the pharyngeal walls.
        Int J Radiat Oncol Biol Phys. 1978; 4: 579-585
        • Bataini P.
        • Brugere J.
        • Bernier J.
        • et al.
        Results of radical radiotherapeutic treatment of carcinoma of the pyriform sinus: Experience of the Institut Curie.
        Int J Radiat Oncol Biol Phys. 1982; 8: 1277-1286
        • Chen S.W.
        • Yang S.N.
        • Liang J.A.
        • et al.
        Value of computed tomography-based tumor volume as a predictor of outcomes in hypopharyngeal cancer after treatment with definitive radiotherapy.
        Laryngoscope. 2006; 116: 2012-2017
        • Zbaren P.
        • Egger C.
        Growth patterns of piriform sinus carcinomas.
        Laryngoscope. 1997; 107: 511-518
        • Deleyiannis F.W.
        • Piccirillo J.F.
        • Kirchner J.A.
        Relative prognostic importance of histologic invasion of the laryngeal framework by hypopharyngeal cancer.
        Ann Otol Rhinol Laryngol. 1996; 105: 101-108
        • Becker M.
        Neoplastic invasion of laryngeal cartilage: Radiologic diagnosis and therapeutic implications.
        Eur J Radiol. 2000; 33: 216-229
        • Hsu W.C.
        • Loevner L.A.
        • Karpati R.
        • et al.
        Accuracy of magnetic resonance imaging in predicting absence of fixation of head and neck cancer to the prevertebral space.
        Head Neck. 2005; 27: 95-100
        • Hull M.C.
        • Morris C.G.
        • Tannehill S.P.
        • et al.
        Definitive radiotherapy alone or combined with a planned neck dissection for squamous cell carcinoma of the pharyngeal wall.
        Cancer. 2003; 98: 2224-2231
        • Wang C.C.
        Radiotherapeutic management of carcinoma of the posterior pharyngeal wall.
        Cancer. 1971; 27: 894-896
        • Lefebvre J.L.
        • Castelain B.
        • De la Torre J.C.
        • et al.
        Lymph node invasion in hypopharynx and lateral epilarynx carcinoma: A prognostic factor.
        Head Neck Surg. 1987; 10: 14-18
        • Bernier J.
        • Bataini J.P.
        Regional outcome in oropharyngeal and pharyngolaryngeal cancer treated with high dose per fraction radiotherapy: Analysis of neck disease response in 1646 cases.
        Radiother Oncol. 1986; 6: 87-103
        • Mendenhall W.M.
        • Million R.R.
        • Cassisi N.J.
        Squamous cell carcinoma of the head and neck treated with radiation therapy: The role of neck dissection for clinically positive neck nodes.
        Int J Radiat Oncol Biol Phys. 1986; 12: 733-740
        • Barkley Jr., H.T.
        • Fletcher G.H.
        • Jesse R.H.
        • et al.
        Management of cervical lymph node metastases in squamous cell carcinoma of the tonsillar fossa, base of tongue, supraglottic larynx, and hypopharynx.
        Am J Surg. 1972; 124: 462-467
        • Mendenhall W.M.
        • Villaret D.B.
        • Amdur R.J.
        • et al.
        Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck.
        Head Neck. 2002; 24: 1012-1018
        • Verschuur H.P.
        • Keus R.B.
        • Hilgers F.J.
        • et al.
        Preservation of function by radiotherapy of small primary carcinomas preceded by neck dissection for extensive nodal metastases of the head and neck.
        Head Neck. 1996; 18: 277-282
        • Allal A.S.
        • Dulguerov P.
        • Bieri S.
        • et al.
        A conservation approach to pharyngeal carcinoma with advanced neck disease: optimizing neck management.
        Head Neck. 1999; 21: 217-222
        • Corvo R.
        Evidence-based radiation oncology in head and neck squamous cell carcinoma.
        Radiother Oncol. 2007; 85: 156-170
        • Wendt T.G.
        • Grabenbauer G.G.
        • Rodel C.M.
        • et al.
        Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study.
        J Clin Oncol. 1998; 16: 1318-1324
        • Calais G.
        • Alfonsi M.
        • Bardet E.
        • et al.
        Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma.
        J Natl Cancer Inst. 1999; 91: 2081-2086
        • Corry J.
        • Peters L.
        • Fisher R.
        • et al.
        N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders-results of Trans Tasman Radiation Oncology Group Study 98.02.
        Head Neck. 2008; 30: 737-742
        • Machtay M.
        • Moughan J.
        • Trotti A.
        • et al.
        Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis.
        J Clin Oncol. 2008; 26: 3582-3589


      Commenting Guidelines

      To submit a comment for a journal article, please use the space above and note the following:

      • We will review submitted comments as soon as possible, striving for within two business days.
      • This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
      • We require that commenters identify themselves with names and affiliations.
      • Comments must be in compliance with our Terms & Conditions.
      • Comments are not peer-reviewed.